Mangoceuticals, Inc.MGRX
Price (close)
$0.46
Market cap
—
P/E
—
Revenue (TTM)
$315,227
Net income
-$15.1M
Dividend yield
—
1-year total return
-79.4%
Net margin
-4791.3%
Revenue growth
-38.9%
Debt / equity
—
What Mangoceuticals, Inc. does.
information included in this Report on Form 10-K should be read in conjunction with the consolidated financial statements and related
logo and some of our trademarks and tradenames are used in this Report. This Report also includes trademarks, tradenames and service
marks that are the property of others. Solely for convenience, trademarks, tradenames, and service marks referred to in this Report may
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $8,939 | $731,493 | $615,873 | $456,021 |
| Net income | — | -$2.0M | -$9.2M | -$8.7M | -$20.6M |
| Free cash flow | — | -$1.4M | -$7.0M | — | — |
More on MGRX.
- Mangoceuticals, Inc. summary
- Mangoceuticals, Inc. financial statements
- Mangoceuticals, Inc. key metrics
- Mangoceuticals, Inc. health scores and style box
- Mangoceuticals, Inc. earnings
- Mangoceuticals, Inc. dividends
- Mangoceuticals, Inc. valuation
- Mangoceuticals, Inc. ownership and insiders
- Mangoceuticals, Inc. peers
Figures from Mangoceuticals, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.